Pomalidomide Labeled an Advance in Multiple Myeloma
December 12th 2012The combination of pomalidomide and a steroid significantly improved outcomes for patients with multiple myeloma who have exhausted other novel therapies, marking what researchers say is a notable advancement for a sizable proportion of those treated for the disease.
Read More
2 Commerce Drive
Cranbury, NJ 08512